carbonthatcarbonthat
← Every company

Who Owns Halozyme Therapeutics Inc

Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Halozyme Therapeutics Inc.

Who crossed 5% of HALO →
Managers holding
28
as of 2026-09-30
Reported value
$277.2M
summed across filings
Shares held
2.5M
Added vs trimmed
5 / 11
since each filer's last quarter

Positions as of 2026-09-30

Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.

ManagerValue
CONGRESS ASSET MANAGEMENT COCOM2.3M shadded$251.9M
Artemis Investment Management LLPCOM108.3K shheld$12M
Monument Capital ManagementCOM28.5K sh—$3.1M
Gradient Investments LLCCOM15K shtrimmed$1.7M
JUNCTURE WEALTH STRATEGIES, LLCCOM11.6K shtrimmed$1.3M
Farther Finance Advisors, LLCStock11.1K shtrimmed$1.2M
MRA Advisory GroupCOM6.7K shtrimmed$741.1K
COLLECTIVE FAMILY OFFICE LLCCOM6.3K shtrimmed$697K
GAMMA Investing LLCCommon Stock5.5K shadded$606.4K
Whalen Wealth Management Inc.COM5.3K shtrimmed$582.3K
Legacy Wealth Asset Management, LLCCOM5.2K shadded$575.2K
ARGENT CAPITAL MANAGEMENT LLCCOM5.1K shtrimmed$560.7K
TITLEIST ASSET MANAGEMENT, LLCCOM4.8K shheld$530.8K
Balefire, LLCCOM3.2K shadded$356.3K
JOURNEY RETIREMENT PLANNING & INVESTMENT MANAGEMENT LLCCOM3K shtrimmed$332.1K
Wedmont Private CapitalCOM2.7K sh—$293.6K
Whitaker-Myers Wealth Managers, LTD.COM2.2K sh—$247.3K
Pacific Wealth ManagementCOM2.2K shtrimmed$241.1K
GK Wealth Management LLCCOM1.6K sh—$177.5K
MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock470 shtrimmed$51.9K
CoreCap Advisors, LLCStock303 shadded$33.5K
ARMSTRONG ADVISORY GROUP, INCCOM300 shheld$33.1K
AMERICAN NATIONAL BANK & TRUSTCOM109 shtrimmed$12K
Byrne Asset Management LLCCOM80 shheld$8.6K
MJT & Associates Financial Advisory Group, Inc.Stock41 shheld$4.5K
ELEVATION WEALTH PARTNERS, LLCCOM28 shheld$3.1K
TOTH FINANCIAL ADVISORY CORPCOM25 shheld$2.8K
Retirement Wealth Solutions LLCCOM23 shheld$2.5K

Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.

More on HALO

Company overviewEverything on HALO in one place, with the price.SEC filingsWhat HALO's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat HALO's own officers and directors buy and sell.Planned salesSales HALO insiders have filed notice of.Funds holding itWhich funds and ETFs hold HALO, and how big a bet.LobbyingWhat HALO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HALO's account, and who they worked for.PatentsWhat HALO is filing at the patent office.

Follow Halozyme Therapeutics Inc (HALO) by email

New trades in Halozyme Therapeutics Inc (HALO) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.